T cells play a central role in immunity to viruses but our knowledge of what is required at the cellular and molecular level to generate an anti-viral T cell response is not as extensive as it needs to be in order to formulate effective and long-lasting vaccines based on virus vectors. We propose to study the requirement and role of several TNF/TNFR superfamily molecules in the development of the anti-viral T cell response to vaccinia virus. We propose that these molecules might be targets for improving our ability to effectively vaccinate. Poxvirus-based vectors are being used as vaccine candidates for many pathogens that we have failed to effectively control, including HIV, HSV, malaria, and tuberculosis. We have found that two interactions within the TNFR family, namely OX40/OX40L and CD27/CD70, play essential non-redundant roles in directing the priming of CD8 and CD4 T cells induced by the most virulent strain of one poxvirus, vaccinia virus. Our future studies propose to understand how targeting these molecules, and new members of the TNFR family, can promote quantitative and qualitative aspects of T cell memory that will allow attenuated poxvirus vectors to be used successfully for vaccination while maintaining the safety of these vaccines. By understanding how the availability of the TNFR proteins and their TNF ligands are controlled by the immune system and the virus, we hope to gain greater insight into how virus-reactive T cells are regulated, which will be of use for understanding how protection against many viruses can be achieved. By focusing on molecules such as those in the TNFR/TNF superfamilies, this is likely to lead to development of new clinical targets for promoting more efficient vaccination strategies.

Public Health Relevance

Membrane-expressed stimulatory molecules are often crucial for immune responses amplifying the responses of T cells. OX40 (CD134) and OX40L, CD27 and CD70, and other members of the TNFR/TNF superfamily, are molecules whose functions are slowly being unraveled. Our data have shown that some of these interactions provide essential signals to allow vaccinia virus reactive T cells to expand in numbers, and gain functionality, which is critical for an effective immune response against the virus. Vaccinia virus was used to immunize against smallpox, resulting in its eradication many years ago, and now vectors based on vaccinia are being developed as vaccines for other viruses and infectious diseases. By focusing on molecules in the TNFR/TNF superfamilies, this might lead to development of new targets for promoting more efficient or alternative vaccination strategies.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Immunity and Host Defense Study Section (IHD)
Program Officer
Challberg, Mark D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
La Jolla Institute
La Jolla
United States
Zip Code
Tahiliani, Vikas; Hutchinson, Tarun E; Abboud, Georges et al. (2017) OX40 Cooperates with ICOS To Amplify Follicular Th Cell Development and Germinal Center Reactions during Infection. J Immunol 198:218-228
Boettler, Tobias; Choi, Youn Soo; Salek-Ardakani, Shahram et al. (2013) Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1. J Immunol 191:5026-35
Flynn, Rachel; Hutchinson, Tarun; Murphy, Kenneth M et al. (2013) CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA. PLoS One 8:e77991
Gerlic, Motti; Faustin, Benjamin; Postigo, Antonio et al. (2013) Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation. Proc Natl Acad Sci U S A 110:7808-13
Boettler, Tobias; Moeckel, Friedrich; Cheng, Yang et al. (2012) OX40 facilitates control of a persistent virus infection. PLoS Pathog 8:e1002913
Goulding, John; Bogue, Rebecka; Tahiliani, Vikas et al. (2012) CD8 T cells are essential for recovery from a respiratory vaccinia virus infection. J Immunol 189:2432-40
Zhao, Yuan; Croft, Michael (2012) Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells. Immunol Lett 141:220-6
Fousteri, Georgia; Dave, Amy; Morin, Bret et al. (2011) Nasal cardiac myosin peptide treatment and OX40 blockade protect mice from acute and chronic virally-induced myocarditis. J Autoimmun 36:210-20
Salek-Ardakani, Shahram; Moutaftsi, Magdalini; Sette, Alessandro et al. (2011) Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection. J Virol 85:9051-9
Salek-Ardakani, Shahram; Flynn, Rachel; Arens, Ramon et al. (2011) The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J Clin Invest 121:296-307

Showing the most recent 10 out of 18 publications